US$ 25.66
soul trial oral semaglutide cardiovascular outcomes nejm 2025 results and in Patients with Type 2 Diabetes Trial Scorecard: SOUL
Description
People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs

A proven GLP-1 treatment tailored to support appetite control and long-term results.

It is not indicated for type 1 diabetes or diabetic ketoacidosis

Can you take tirzepatide with SSRIs like Zoloft or Lexapro

PlexusDx explains what research shows about this popular supplement pairing

Results and eligibility may vary based on individual medical history